Article Correctness Is Author's Responsibility: Landmark International Study: CAR T-Cell Therapy Safe and Effective in Children and Young Adults with Leukemia

Results of the global, multicenter, pivotal phase 2 study that led to the first FDA approval of a gene therapy/cell therapy approach known as CAR T-cell therapy, were published today in the New England Journal of Medicine.